Artivion strengthens aortic arch portfolio with $135M Endospan acquisition

Mergers & Acquisitions
Artivion has acquired Endospan in a $135m upfront deal, exercising a license option to buy the Israeli company upon US Food and Drug Administration (FDA) approval for its NEXUS aortic graft stent system. As per...

Artivion strengthens aortic arch portfolio with $135M Endospan acquisition

Mergers & Acquisitions
Artivion has acquired Endospan in a $135m upfront deal, exercising a license option to buy the Israeli company upon US Food and Drug Administration...

Cagent Vascular closes $41M Series D, reports first-in-human IVL cases

Funding
Cagent Vascular announced the first-in-human cases with its Serranator Sonic IVL system alongside significant funding. In addition to the first human use of the intravascular...

Boston Scientific invests $1.5B in MiRus, enters $2B share repurchase agreement

Funding
Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus. Marlborough, Massachusetts–based Boston Scientific now has an equity stake...

EmStop initiates IDE study of novel embolic protection device

Clinical Trials
EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

EmStop initiates IDE study of novel embolic protection device

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

Reprieve Cardiovascular pilot study backs heart failure system

Reprieve Cardiovascular announced the publication of results from a pilot study of its heart failure therapy. Milford, Massachusetts-based Reprieve Cardiovascular develops the Reprieve Therapy. It...

MMI completes first robotic-assisted procedure in Alzheimer’s patient

Medical Microinstruments (MMI) announced the completion of the first robotic-assisted procedure in its REMIND U.S. IDE study. REMIND evaluates microsurgical intervention for neurodegenerative disease. MMI...

CVRx enrolls first patient in study of Barostim therapy for heart failure

CVRx announced that it enrolled the first patient in its landmark BENEFIT-HF study of its Barostim therapy. Barostim delivers electrical pulses to baroreceptors in the...

Innovation

Regulatory Approvals

Artivion strengthens aortic arch portfolio with $135M Endospan acquisition

Artivion has acquired Endospan in a $135m upfront deal, exercising a license option to buy the Israeli company upon US Food and Drug Administration...

Cagent Vascular closes $41M Series D, reports first-in-human IVL cases

Cagent Vascular announced the first-in-human cases with its Serranator Sonic IVL system alongside significant funding. In addition to the first human use of the intravascular...

Boston Scientific invests $1.5B in MiRus, enters $2B share repurchase agreement

Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus. Marlborough, Massachusetts–based Boston Scientific now has an equity stake...

EmStop initiates IDE study of novel embolic protection device

EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1138Regulatory Approvals1016Innovation655Clinical Trials521Mergers & Acquisitions507GS Funding Tracker49